Total Payments
$2,181
2024 Payments
$64.27
Companies
9
Transactions
34
Medicare Patients
4,479
Medicare Billing
$366,099
Payment Breakdown by Category
Education$1,397 (64.0%)
Food & Beverage$784.45 (36.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $1,397 | 1 | 64.0% |
| Food and Beverage | $784.45 | 33 | 36.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Arthrex, Inc. | $1,426 | 2 | $0 (2017) |
| Organogenesis Inc. | $239.96 | 16 | $0 (2024) |
| Stryker Corporation | $149.94 | 1 | $0 (2018) |
| DePuy Synthes Sales Inc. | $114.42 | 1 | $0 (2019) |
| Paratek Pharmaceuticals, Inc. | $86.15 | 5 | $0 (2024) |
| Smith+Nephew, Inc. | $85.99 | 6 | $0 (2023) |
| AXOGEN | $48.94 | 1 | $0 (2023) |
| Advanced Oxygen Therapy Inc. | $17.93 | 1 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $12.58 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $64.27 | 2 | Organogenesis Inc. ($39.99) |
| 2023 | $159.26 | 5 | Organogenesis Inc. ($76.07) |
| 2022 | $48.41 | 3 | Organogenesis Inc. ($24.33) |
| 2020 | $75.31 | 5 | Paratek Pharmaceuticals, Inc. ($42.02) |
| 2019 | $175.51 | 6 | DePuy Synthes Sales Inc. ($114.42) |
| 2018 | $233.15 | 11 | Stryker Corporation ($149.94) |
| 2017 | $1,426 | 2 | Arthrex, Inc. ($1,426) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/08/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: ANTIBIOTIC | ||||||
| 01/23/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $39.99 | General |
| 08/22/2023 | AXOGEN | Avance Nerve Graft (Device) | Food and Beverage | Cash or cash equivalent | $48.94 | General |
| Category: Neurology | ||||||
| 04/11/2023 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $44.13 | General |
| Category: Wound Care | ||||||
| 03/16/2023 | Smith+Nephew, Inc. | REGRANEX (Drug), COLLAGENASE SANTYL | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Pharma Products | ||||||
| 01/19/2023 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $31.94 | General |
| Category: Wound Care | ||||||
| 01/17/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: ANTIBIOTIC | ||||||
| 08/09/2022 | Smith+Nephew, Inc. | REGRANEX (Drug), COLLAGENASE SANTYL | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: Pharma Products | ||||||
| 06/20/2022 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $24.33 | General |
| Category: WOUND CARE | ||||||
| 04/19/2022 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug), REGRANEX | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: Pharma Products | ||||||
| 11/12/2020 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: ANTIBIOTIC | ||||||
| 10/20/2020 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: ANTIBIOTIC | ||||||
| 10/08/2020 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: ANTIBIOTIC | ||||||
| 09/22/2020 | Smith+Nephew, Inc. | Santyl (Drug), REGRANEX | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Pharma Product | ||||||
| 03/17/2020 | Smith+Nephew, Inc. | Santyl (Drug), REGRANEX | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Pharma Product | ||||||
| 11/12/2019 | Advanced Oxygen Therapy Inc. | — | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Topical oxygen chamber for extremities | ||||||
| 07/25/2019 | Merck Sharp & Dohme Corporation | SIVEXTRO (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/12/2019 | Smith+Nephew, Inc. | Santyl (Drug), REGRANEX | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Pharma Product | ||||||
| 06/28/2019 | Organogenesis Inc. | Apligraf (Device) | Food and Beverage | Cash or cash equivalent | $1.07 | General |
| Category: Wound Care | ||||||
| 05/23/2019 | DePuy Synthes Sales Inc. | TFN ADVANCED (Device), EXPAREL | Food and Beverage | In-kind items and services | $114.42 | General |
| Category: Trauma | ||||||
| 02/14/2019 | Organogenesis Inc. | Apligraf (Biological) | Food and Beverage | Cash or cash equivalent | $15.29 | General |
| Category: Wound Care | ||||||
| 10/30/2018 | Organogenesis Inc. | Apligraf (Biological) | Food and Beverage | Cash or cash equivalent | $4.66 | General |
| Category: Podiatry | ||||||
| 10/18/2018 | Organogenesis Inc. | Apligraf (Biological) | Food and Beverage | Cash or cash equivalent | $9.40 | General |
| Category: Podiatry | ||||||
| 06/28/2018 | Organogenesis Inc. | Apligraf (Biological) | Food and Beverage | Cash or cash equivalent | $16.07 | General |
| Category: Podiatry | ||||||
| 06/14/2018 | Organogenesis Inc. | Apligraf (Biological) | Food and Beverage | Cash or cash equivalent | $14.96 | General |
| Category: Podiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,051 | 2,102 | $162,090 | $86,793 |
| 2022 | 18 | 1,166 | 2,176 | $173,525 | $89,485 |
| 2021 | 18 | 1,312 | 2,344 | $197,130 | $112,689 |
| 2020 | 15 | 950 | 2,021 | $153,360 | $77,132 |
Total Patients
4,479
Total Services
8,643
Medicare Billing
$366,099
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 199 | 372 | $35,340 | $23,746 | 67.2% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2023 | 174 | 467 | $28,020 | $14,008 | 50.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 137 | 137 | $19,180 | $9,500 | 49.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 49 | 88 | $13,200 | $6,892 | 52.2% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2023 | 55 | 110 | $9,900 | $6,082 | 61.4% |
| 11057 | Removal of noncancer thickened skin growth, more than 4 growths | Office | 2023 | 35 | 95 | $9,975 | $5,744 | 57.6% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2023 | 18 | 67 | $7,035 | $5,236 | 74.4% |
| 11720 | Removal of fingernails or toenails, 1-5 nails | Office | 2023 | 102 | 212 | $10,600 | $4,768 | 45.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 60 | 76 | $4,940 | $3,020 | 61.1% |
| 11055 | Removal of noncancer thickened skin growth, 1 growth | Office | 2023 | 25 | 45 | $3,150 | $2,232 | 70.9% |
| G0127 | Trimming of dystrophic nails, any number | Office | 2023 | 67 | 185 | $9,250 | $2,035 | 22.0% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 54 | 80 | $6,400 | $1,893 | 29.6% |
| 29540 | Placement of strapping to ankle or foot | Office | 2023 | 43 | 76 | $4,180 | $1,592 | 38.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 17 | 47 | $470.00 | $39.49 | 8.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 16 | 45 | $450.00 | $4.40 | 1.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 203 | 360 | $34,200 | $21,884 | 64.0% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2022 | 203 | 492 | $29,520 | $14,607 | 49.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 133 | 133 | $18,620 | $9,738 | 52.3% |
| 11057 | Removal of noncancer thickened skin growth, more than 4 growths | Office | 2022 | 47 | 129 | $13,135 | $7,356 | 56.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 52 | 97 | $14,550 | $7,123 | 49.0% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2022 | 71 | 118 | $10,120 | $6,260 | 61.9% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2022 | 22 | 68 | $7,140 | $5,045 | 70.7% |
| 11720 | Removal of fingernails or toenails, 1-5 nails | Office | 2022 | 104 | 199 | $9,950 | $4,144 | 41.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 51 | 65 | $4,225 | $2,546 | 60.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $6,600 | $2,376 | 36.0% |
About Dr. James Farrell, DPM
Dr. James Farrell, DPM is a Foot Surgery healthcare provider based in Liverpool, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841240652.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Farrell, DPM has received a total of $2,181 in payments from pharmaceutical and medical device companies, with $64.27 received in 2024. These payments were reported across 34 transactions from 9 companies. The most common payment nature is "Education" ($1,397).
As a Medicare-enrolled provider, Farrell has provided services to 4,479 Medicare beneficiaries, totaling 8,643 services with total Medicare billing of $366,099. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Foot Surgery
- Location Liverpool, NY
- Active Since 05/11/2006
- Last Updated 04/10/2014
- Taxonomy Code 213ES0131X
- Entity Type Individual
- NPI Number 1841240652
Products in Payments
- ANCHORAGE (Device) $149.94
- TFN ADVANCED (Device) $114.42
- Puraply (Medical Supply) $100.40
- Apligraf (Biological) $92.02
- NUZYRA (Drug) $86.15
- Avance Nerve Graft (Device) $48.94
- Santyl (Drug) $47.51
- REGRANEX (Drug) $26.44
- SIVEXTRO (Drug) $12.58
- COLLAGENASE SANTYL (Drug) $12.04
- Dermagraft (Device) $6.48
- Apligraf (Device) $1.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.